Published in World J Cardiol on June 26, 2017
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med (2002) 27.55
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med (1996) 15.04
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med (2004) 10.02
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med (2001) 9.75
Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med (2012) 8.84
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. N Engl J Med (2016) 7.87
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med (2004) 7.12
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med (2005) 6.86
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis (2012) 5.70
Defibrillator implantation early after myocardial infarction. N Engl J Med (2009) 5.25
Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation (2004) 3.78
Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol (2010) 3.18
Medicare coverage of ICDs. N Engl J Med (2005) 2.67
Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol (2004) 2.63
From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation (1999) 2.34
Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol (2007) 2.29
Predictors of outcome in patients with suspected myocarditis. Circulation (2008) 2.03
Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac Patients: Data From the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry). Circulation (2015) 2.01
Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation (2002) 1.93
Mortality in Medicare beneficiaries following coronary artery bypass graft surgery in states with and without certificate of need regulation. JAMA (2002) 1.85
Pregnancy-related mortality due to cardiomyopathy: United States, 1991-1997. Obstet Gynecol (2003) 1.84
Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am Coll Cardiol (2013) 1.83
Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythm Electrophysiol (2012) 1.66
Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol (2011) 1.65
Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation. Heart Rhythm (2015) 1.57
Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator. Eur J Heart Fail (2014) 1.52
Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy: A Decade-Long Single-Center Experience. J Am Coll Cardiol (2015) 1.48
Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Pacing Clin Electrophysiol (2009) 1.47
Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death. Circulation (2016) 1.44
Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators. J Am Coll Cardiol (2006) 1.42
Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int (2005) 1.41
A fatal device-device interaction between a wearable automated defibrillator and a unipolar ventricular pacemaker. Pacing Clin Electrophysiol (2008) 1.01
Sudden cardiac arrest in hemodialysis patients with wearable cardioverter defibrillator. Ann Noninvasive Electrocardiol (2013) 0.93
Clinical efficacy of the wearable cardioverter-defibrillator in acutely terminating episodes of ventricular fibrillation. Am J Cardiol (1998) 0.90
Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator. Pacing Clin Electrophysiol (2013) 0.89
Non-invasive evaluation of arrhythmic risk in dilated cardiomyopathy: From imaging to electrocardiographic measures. World J Cardiol (2014) 0.85
Prevalence and Clinical Significance of Life-Threatening Arrhythmias in Takotsubo Cardiomyopathy. J Am Coll Cardiol (2015) 0.84
Management of arrhythmias in patients with Takotsubo cardiomyopathy: Is the implantation of permanent devices necessary? Heart Rhythm (2016) 0.84
Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory From the American Heart Association. Circulation (2016) 0.82
National experience with long-term use of the wearable cardioverter defibrillator in patients with cardiomyopathy. J Interv Card Electrophysiol (2016) 0.81
Arrhythmias in peripartum cardiomyopathy. Card Electrophysiol Clin (2015) 0.79
Use of implantable cardioverter defibrillators in patients with left ventricular assist devices. Eur J Heart Fail (2012) 0.77
The Wearable Cardioverter Defibrillator in Nonischemic Cardiomyopathy: A US National Database Analysis. Can J Cardiol (2016) 0.76
Arrhythmogenic mortality in heart-transplant candidates. Transpl Int (1996) 0.76
Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis. J Heart Lung Transplant (2015) 0.76
Wearable cardioverter defibrillator in stress cardiomyopathy and cardiac arrest. BMJ Case Rep (2013) 0.76
WCD LifeVest: risk stratification in a case of Tako-Tsubo cardiomyopathy with QT interval prolongation. Herz (2011) 0.76
Timing the implantation of implantable cardioverter-defibrillators in patients with nonischemic cardiomyopathy. J Am Coll Cardiol (2006) 0.76
Cardiac implantable electronic device infection in patients with end-stage renal disease. Heart Rhythm (2015) 0.76